INTEGRA LIFESCIENCES HOLDINGS CORP Cash And Cash Equivalents At Carrying Value

Quick Answer

INTEGRA LIFESCIENCES HOLDINGS CORP reported Cash And Cash Equivalents At Carrying Value of $235.05 million for the year ending 2025.

  • INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -4.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from INTEGRA LIFESCIENCES HOLDINGS CORP's annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 19 years of available data (2007 to 2025), INTEGRA LIFESCIENCES HOLDINGS CORP's Cash And Cash Equivalents At Carrying Value has grown by 309.9%.
  • Historical annual values: Fiscal year 2025: $235.05 million | Fiscal year 2024: $246.38 million | Fiscal year 2023: $276.40 million | Fiscal year 2022: $456.66 million | Fiscal year 2021: $513.45 million | Fiscal year 2020: $470.17 million | Fiscal year 2019: $198.91 million | Fiscal year 2018: $138.84 million | Fiscal year 2017: $174.94 million | Fiscal year 2016: $102.06 million | Fiscal year 2015: $48.13 million | Fiscal year 2014: $71.73 million | Fiscal year 2013: $120.61 million | Fiscal year 2012: $96.94 million | Fiscal year 2011: $100.81 million | Fiscal year 2010: $128.76 million | Fiscal year 2009: $71.89 million | Fiscal year 2008: $183.55 million | Fiscal year 2007: $57.34 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: